Conditions: Obesity Type 2 Diabetes
Keywords: Pioglitazone prediabetes diabetes obesity Pancreatic fat
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 42
Healthy volunteers: no

Brief summary:
Randomized, double blind, placebo controlled trial evaluating the effect of pioglitazone on pancreatic fat content and bone turnover markers.

Detailed description:

Arms:
arm 1: pioglitazone tablet 45 mg once daily arm 2: placebo pill once daily (look-alike pill which contains no active ingredients)

Interventions: intervention 1: pioglitazone intervention 2: placebo
Intervention descriptions: intervention 1: pioglitazone 45 mg daily intervention 2: one daily

Protocol document: